1. Home
  2. ARQT vs AVA Comparison

ARQT vs AVA Comparison

Compare ARQT & AVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • AVA
  • Stock Information
  • Founded
  • ARQT 2016
  • AVA 1889
  • Country
  • ARQT United States
  • AVA United States
  • Employees
  • ARQT N/A
  • AVA N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • AVA Power Generation
  • Sector
  • ARQT Health Care
  • AVA Utilities
  • Exchange
  • ARQT Nasdaq
  • AVA Nasdaq
  • Market Cap
  • ARQT 3.3B
  • AVA 3.2B
  • IPO Year
  • ARQT 2020
  • AVA N/A
  • Fundamental
  • Price
  • ARQT $28.01
  • AVA $40.79
  • Analyst Decision
  • ARQT Strong Buy
  • AVA Hold
  • Analyst Count
  • ARQT 7
  • AVA 2
  • Target Price
  • ARQT $22.17
  • AVA $39.50
  • AVG Volume (30 Days)
  • ARQT 3.1M
  • AVA 634.6K
  • Earning Date
  • ARQT 10-28-2025
  • AVA 11-05-2025
  • Dividend Yield
  • ARQT N/A
  • AVA 4.82%
  • EPS Growth
  • ARQT N/A
  • AVA N/A
  • EPS
  • ARQT N/A
  • AVA 2.35
  • Revenue
  • ARQT $317,929,000.00
  • AVA $1,964,000,000.00
  • Revenue This Year
  • ARQT $85.27
  • AVA $2.58
  • Revenue Next Year
  • ARQT $30.70
  • AVA $1.16
  • P/E Ratio
  • ARQT N/A
  • AVA $17.30
  • Revenue Growth
  • ARQT 129.21
  • AVA 2.14
  • 52 Week Low
  • ARQT $9.19
  • AVA $34.80
  • 52 Week High
  • ARQT $28.96
  • AVA $43.09
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 71.06
  • AVA 60.56
  • Support Level
  • ARQT $22.26
  • AVA $40.74
  • Resistance Level
  • ARQT $24.39
  • AVA $41.34
  • Average True Range (ATR)
  • ARQT 1.46
  • AVA 0.65
  • MACD
  • ARQT 0.21
  • AVA 0.01
  • Stochastic Oscillator
  • ARQT 85.67
  • AVA 71.18

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

Share on Social Networks: